Wells Fargo
LENZ

Wells Fargo’s LENZ Therapeutics LENZ Stock Holding History

Wells Fargo’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$101K Buy
17,792
+3,820
+27% +$30.8K ﹤0.01% 5528
2026
Q1 		$128K Sell
13,972
-8,944
-39% -$126K ﹤0.01% 4963
2025
Q4 		$367K Buy
22,916
+12,468
+119% +$363K ﹤0.01% 4698
2025
Q3 		$487K Buy
10,448
+1,122
+12% +$41.3K ﹤0.01% 4325
2025
Q2 		$273K Buy
9,326
+1,657
+22% +$45.1K ﹤0.01% 4573
2025
Q1 		$197K Buy
7,669
+165
+2% +$4.06K ﹤0.01% 4714
2024
Q4 		$217K Buy
7,504
+1,608
+27% +$49K ﹤0.01% 4753
2024
Q3 		$140K Buy
5,896
+247
+4% +$5.48K ﹤0.01% 4817
2024
Q2 		$97.7K Buy
5,649
+4,290
+316% +$74.9K ﹤0.01% 4954
2024
Q1 		$30.3K Buy
1,359
+54
+4% +$1.12K ﹤0.01% 5447
2023
Q4 		$23.9K Buy
1,305
+244
+23% +$4.03K ﹤0.01% 5569
2023
Q3 		$18.4K Sell
1,061
-916
-46% -$15.9K ﹤0.01% 5633
2023
Q2 		$36K Buy
1,977
+1,498
+313% +$29.9K ﹤0.01% 5557
2023
Q1 		$8.22K Hold
479
– – ﹤0.01% 5923
2022
Q4 		$11.1K Sell
479
-28
-6% -$649 ﹤0.01% 5505
2022
Q3 		$12K Buy
507
+12
+2% +$286 ﹤0.01% 5625
2022
Q2 		$9K Sell
495
-962
-66% -$21.4K ﹤0.01% 5813
2022
Q1 		$52K Sell
1,457
-388
-21% -$24.3K ﹤0.01% 5642
2021
Q4 		$160K Buy
1,845
+1,423
+337% +$118K ﹤0.01% 5389
2021
Q3 		$48K Buy
+422
New +$62.5K ﹤0.01% 5643

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Wells Fargo's LENZ Position: Q2 2026 in Review

Wells Fargo increased its LENZ Therapeutics (LENZ) stake by 27% in Q2 2026, buying an estimated $30.8K and bringing the position to 17,792 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #5528.

Wells Fargo first reported a position in LENZ in Q3 2021 and has held it in 20 quarters since. The position peaked at $487K in Q3 2025. 144 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Wells Fargo held 17,792 shares of LENZ Therapeutics worth $101K as of Q2 2026.
  • Wells Fargo bought 3,820 LENZ Therapeutics shares in Q2 2026, an estimated $30.8K.
  • LENZ Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5528 holding.
  • Wells Fargo first reported a position in LENZ Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • Wells Fargo's LENZ Therapeutics position peaked at $487K in Q3 2025.
  • 144 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.